WallStreetZenWallStreetZen

NASDAQ: AVBP
Arrivent Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Arrivent Biopharma earnings were -$145.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest AVBP earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$43.3M, up 21.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AVBP reported annual earnings of -$166.3M, with 106.6% growth.

AVBP earnings history

Current Revenue
$0.0
Current Earnings
-$145.2M
Current Profit Margin
0%

AVBP Return on Equity

Current Company
-49%
Current Industry
-141.9%
Current Market
13.5%
AVBP's Return on Equity (-49%)... subscribe to Premium to read more.
High Return on Equity Performance

AVBP Return on Assets

Current Company
-45.4%
Current Industry
-13.7%
AVBP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AVBP announces earnings.

AVBP Return on Capital Employed

Current Company
-44.79%
Current Industry
-9.5%

AVBP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AVBP-$145.24M-$145.24MN/A-$3.47
IMCR$6.07M-$27.57MN/A-$0.54
ATAI-$661.66M-$663.40MN/A-$2.82
COAGN/AN/AN/AN/A
NVAX-$42.13M-$87.84MN/A-$0.54
View Top Biotech Stocks

Arrivent Biopharma Earnings Reports & History FAQ

What were Arrivent Biopharma's earnings last quarter?

Arrivent Biopharma (NASDAQ: AVBP) reported Q1 2026 earnings per share (EPS) of -$0.96, up 49.47% year over year. Total AVBP earnings for the quarter were -$43.32 million. In the same quarter last year, Arrivent Biopharma's earnings per share (EPS) was -$1.90.

If you're new to stock investing, here's how to buy Arrivent Biopharma stock.

Is Arrivent Biopharma profitable or losing money?

As of the last Arrivent Biopharma earnings report, Arrivent Biopharma is currently losing money. Arrivent Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$145.24 million, a 13.95% increase year over year.

What was AVBP's earnings growth in the past year?

As of Arrivent Biopharma's earnings date in Q2 2026, Arrivent Biopharma's earnings has grown year over year. AVBP earnings in the past year totalled -$145.24 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.